Lutein: study protocols
20 study groups say how much Lutein participants took a day. These are the doses the studies gave. They are not a recommendation.
Dose per serving from products
3,482 products in our catalogue print how much Lutein a serving holds.
Most common: 10 mg to 25 mg, 26% of 3,482 products.
| Dose per serving | Products |
|---|---|
| 100 mcg or less | 171 |
| 100 mcg to 250 mcg | 269 |
| 250 mcg to 500 mcg | 370 |
| 500 mcg to 1 mg | 200 |
| 1 mg to 2.5 mg | 192 |
| 2.5 mg to 5 mg | 434 |
| 5 mg to 10 mg | 720 |
| 10 mg to 25 mg | 916 |
| 25 mg to 50 mg | 160 |
| over 50 mg | 50 |
Dose per serving from research
20 study groups in 11 studies say how much Lutein participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 5 mg to 10 mg, 50% of 20 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mg to 2.5 mg | 2 |
| 2.5 mg to 5 mg | 2 |
| 5 mg to 10 mg | 10 |
| 10 mg to 25 mg | 6 |
Commonly used together
15 of 20 study groups took Lutein with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Zeaxanthin | 14 |
| Omega-3 Fatty Acids | 3 |
20 study groups
| Study | |||
|---|---|---|---|
| Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration 2015 · 10 mg lutein · Adults aged over 50 with clinically diagnosed early age-related macular degeneration | 10 mg | 2 years | 28 |
| Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration 2015 · 20 mg lutein · Adults aged over 50 with clinically diagnosed early age-related macular degeneration | 20 mg | 2 years | 28 |
| Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial 2013 · lutein + zeaxanthin group · Adults aged 50 to 85 years at risk for progression to advanced age-related macular degeneration, with bilateral large drusen or large drusen in one eye and advanced AMD in the fellow eye | 10 mg | 5 years | — |
| Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 2014 · lutein/zeaxanthin · Adults with high risk of progression to late age-related macular degeneration; mean age 73.1 years; sex not specified | 10 mg | 1789 days | — |
| Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial 2013 · lutein + zeaxanthin and DHA + EPA group · Adults aged 50 to 85 years at risk for progression to advanced age-related macular degeneration, with bilateral large drusen or large drusen in one eye and advanced AMD in the fellow eye | 10 mg | 5 years | — |
| Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 2014 · lutein/zeaxanthin and DHA/EPA · Adults with high risk of progression to late age-related macular degeneration; mean age 73.1 years; sex not specified | 10 mg | 1789 days | — |
| Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration 2015 · lutein (10 mg) + zeaxanthin (10 mg) · Adults aged over 50 with clinically diagnosed early age-related macular degeneration | 10 mg | 2 years | 28 |
| Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A 2010 · lutein + A group · Adults with retinitis pigmentosa | 12 mg | 4 years | — |
| Lutein ester in serum after lutein supplementation in human subjects 1998 · lutein supplementation · Apparently healthy, non-smoking adults aged 25–45 years; nine men and nine women | 15 mg | 120 days | 18 |
| A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses 2002 · Lutein from marigold extracts · Healthy men and women aged 25–45 years from five European regions | 15 mg | — | — |